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ABSTRACT
Exogenous transfer RNAs (tRNAs) favor translation
of bovine papillomavirus 1 wild-type (wt) L1 mRNA
in in vitro translation systems (Zhou et al. 1999,
J. Virol., 73, 4972–4982). We, therefore, investigated
whether papillomavirus (PV) wt L1 protein expres-
sion could be enhanced in eukaryotic cells following
exogenous tRNA supplementation. Both Chinese
hamster ovary (CHO) and Cos1 cells, transfected
with PV1 wt L1 genes, effectively transcribed the
genes but did not translate them. However, L1
protein translation was demonstrated following
co-transfection with the L1 gene and a gene expres-
sing tRNASer(CGA). Cell lines, stably transfected
with a bovine papillomavirus 1 (BPV1) wt L1 expres-
sion construct, produced L1 protein after the trans-
fection of the tRNASer(CGA) gene, but not following
the transfection with basal vectors, suggesting that
tRNASer(CGA) gene enhanced wt L1 translation as a
result of endogenous tRNA alterations and phos-
phorylation of translation initiation factors elF4E
and elF2a in the tRNASer(CGA) transfected L1 cell
lines. The tRNASer(CGA) gene expression signifi-
cantly reduced translation of L1 proteins expressed
from codon-modified (HB) PV L1 genes utilizing
mammalian preferred codons, but had variable
effects on translation of green fluorescent proteins
(GFPs) expressed from six serine GFP variants. The
changes of tRNA pools appear to match the
codon composition of PV wt and HB L1 genes and
serine GFP variants to regulate translation of their
mRNAs. These findings demonstrate for the first
time in eukaryotic cells that translation of the target
genes can be differentially influenced by the provi-
sion of a single tRNA expression construct.
INTRODUCTION
Translation is a key facet of the central dogma of molecular
biology (1), which uses the genetic information in mRNA to
synthesize protein. Transfer RNAs (tRNAs) play a central role
in translation, acting as the carrier of the monomeric units of
proteins, the amino acids and the growing polypeptide chains
(2). Both tRNA and mRNA eventually pair on the ribosome to
determine which amino acid is inserted at a particular point
in the nascent polypeptide chain. To ensure protein synthesis,
correct base pairing between the three bases of the codons on
the mRNAs and those of the anticodons of the cognate ami-
noacyl (aa)-tRNAs dictates the sequence of the polypeptide
chain. In addition, the cellular content of tRNA isoaccepting
species is clearly a determinant of the rates and amounts of
protein synthesis (3). In unicellular organisms, a correlation
between tRNA content constraint and gene expression level
has been demonstrated using the concept of optimal codons
(4). A shortage of critical tRNAs could result in slowed elon-
gation of the nascent peptide or premature termination of
translation (5,6). The tRNAs from uninfected cells can rescue
the translation of global proteins in Autographa california
nucleopolyhedrovirus-infected Ld652Y cells (7). Stimulated
expression of GTase with tRNAAGA and tRNAAGG resulted in
a 5-fold increase in GTase production in Escherichia coli, in
which codon usage is highly biased and the tRNAs specific to
codons AGAarg and AGGarg are extremely rare (8). Expression
of a single tRNA gene has enhanced the expression of hetero-
logous genes, especially for genes containing rare codons in
bacterial expression systems (9,10). The data support the argu-
ment that the variable copy number of individual isoacceptor
tRNAs is a primary determinant of translation (11). However,
it is not clear whether provision of a single tRNA gene expres-
sion can mediate the expression of target genes at either the
transcriptional or translational levels in eukaryotic cells.
The tRNA molecules and tRNA-like structures have been
identified as crucial elements in the replication of a very
diverse group of viruses including plant viruses (12,13)
and mammalian retroviruses (14). Recently, a human
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tRNASer(CGA) gene has been cloned and expressed in
mammalian cells (15,16). The cloned human tRNASer(CGA)
gene containing 400 bp has previously been verified for
its integrity and functionality (15,16), via its ability to act
in reverse transcription of a retroviral vector harboring a com-
plementary primer binding site sequence (16). The human
tRNASer(CGA) molecule was originally identified via a
screening of the human BOSC23 retroviral packaging cell
line (17) for tRNA molecules functionable as primers for
murine leukemia virus (MLV) replication (16). But it is not
clear whether this tRNASer(CGA) molecule could be func-
tional for protein translation of MLV and other viruses.
More recently, tRNA-like structure of turnip yellow mosaic
virus has been reported to be a 30-translational enhancer, which
enhanced expression of a firefly luciferase (LUC) reporter
gene up to 25-fold (18). Therefore, we are interested to inves-
tigate whether and how the expression of the human
tRNASer(CGA) gene would affect the expression of wild-
type (wt) and codon-modified (HB) papillomavirus (PV) L1
genes in cultured mammalian cells.
Both wt and HB PV L1 genes were chosen as the target
genes throughout the experiments; we initially considered the
choice for three reasons. First, PVs are exclusively epithelio-
tropic viruses. The PV life cycle is tightly linked to epithelial
cell differentiation. Production of viral capsid proteins (L1 and
L2) expressed from the late gene (L1 and L2) is restricted to
the most terminally differentiated keratinocytes in the upper
layers of the epithelium. Expression of L1 and L2 proteins
from wt PV L1 and L2 genes has not been observed in pro-
liferating transfected keratinocytes (19) and other replicating
mammalian cells (20). However, mRNAs encoding the capsid
proteins can be detected in less-differentiated keratinocytes
and other replicating mammalian cells, suggesting that the
expression of the late genes is post-transcriptionally regulated
(21). When the L1 and L2 genes are cloned under cytomega-
lovirus (CMV) or simian virus 40 (SV40) promoters in con-
tinuously growing transformed cell lines in transient
transfection assays, large amounts of PV L1 and L2 mRNAs
are made, but no proteins can be detected (20). Second, block-
age to the translation of PV L1 mRNAs has been overcome
by two means: point mutation (19) and codon modification
(20,22–24). Introduction of point mutations in the 50 end of the
L1 gene which altered the RNA sequence without affecting the
protein sequence resulted in the production of high levels of
HPV 16 L1 mRNA and protein in HeLa cells (19). Codon
modification of the PV L1 and L2 genes utilizing mammalian
preferred codons without changing the protein sequence can
express L1 and L2 proteins in large amounts in replicating
mammalian cells (20,22–24). The argument proposed from the
codon modification studies is that codon usage of the PV L1
and L2 genes may be a major determinant of PV capsid protein
expression. The observation we made recently that bovine
papillomavirus (BPV) 1 can undergo its life cycle in BPV1
virus-infected Saccharomyces cerevisiae (25,26) supports this
argument because codon usage of BPV1 genes more closely
resembles that of yeast genes than that of the mammalian
consensus (20). The low expression efficiency of several
viral proteins in HIV due to unfavorable codon usage has
been reported by various groups (27–29). Third, provision
of exogenous tRNAs either from bovine liver or from yeast
could greatly assist the translation of the BPV1 L1 gene and
human PV 16 (HPV16) E7 translation in different in vitro
translation systems (20,30). These observations support the
argument that codon usage of the mRNAs tends to be matched
to the population of tRNAs in cells to regulate the translational
efficiency. Previous studies have indicated that codon usage
in highly expressed genes is biased toward ‘optimal’
codons corresponding to the tRNAs in the tissue or cell envir-
onments (31). Varenne et al. (31) reported that synthesis of a
number of colicins is linked to the difference in tRNA avail-
ability for the various codons. However, it is not clear whether
and how the tRNA abundance in cells matches the correspond-
ing codons in mRNAs of the target genes to regulate their
expression at the translational levels in specific mammalian
cell lines.
In this report, we first examined whether the expression of
the tRNASer(CGA) gene construct could enhance translation
of wt PV L1 mRNAs in two replicating eukaryotic cell lines:
Chinese hamster ovary (CHO) cell system that closely mimics
living cells (32) and Cos1 cells that effectively transcribe wt
PV L1 genes but do not produce L1 proteins (20). We then
established two cell lines, CHO L1 and Cos1 L1, transfected
with a wt BPV1 L1 expression construct, to determine whether
the tRNASer(CGA) gene could assist translation of BPV1 L1
mRNA. At the same time, we examined whether the supple-
ment of exogenous tRNAs would enhance translation of wt PV
L1 mRNAs in cell culture systems. We then examined whether
and how the expression of the tRNASer(CGA) gene affected
the tRNA populations, phosphorylation of the translation
initiation factors elF4E and elF2a, and expression of cellular
proteins in the two L1 cell lines. We further studied whether
the tRNASer(CGA) gene affected the expression of the L1
proteins encoded by two HB PV L1 genes (BPV1 and
HPV6b L1 genes) in which CGA was a rarely used codon
in the two cell lines. Finally, we investigated whether and how
the tRNASer(CGA) gene affected expression of green fluores-
cent proteins (GFPs) expressed from hm gfp gene and six
serine GFP variants, in which a leader sequence of six con-
secutive identical codons from one of the six serine codons
(AGC, AGU, UCA, UCC, UCG and UCU) was introduced
into the hm gfp gene downstream from the AUG codon in
CHO cells.
MATERIALS AND METHODS
Plasmid constructions
The tRNASer(CGA) gene construction. The tRNASer(CGA)
DNA (400 bp) was cut from pGEM-T tRNASer(CGA)
[kindly provided by Lund et al. (15)] and ligated into a pSVneo
vector at the EcoRI site to construct a pSV2tRNASer(CGA)
plasmid [tRNASer(CGA) hereafter].
Construction of wild-type and codon-modified papillomavirus
L1 genes. Plasmids pCDNA3BPV1 L1, pCDNA3BPV1 HB
L1, pCDNA3HPV6b L1 and pCDNA3HPV6b HB L1 used
in the experiments have been described previously (20).
Briefly, both BPV1 and HPV6b wt L1 open-reading frames
(ORFs) are 1.5 kb in length encoding 500 amino acids. The
PV wt L1 genes show a strong codon usage bias, amongst
degenerately encoded amino acids, toward 18 codons mainly
with T at the third position that are rarely used by mammalian
genes (20,33). We artificially modified BPV1 and HPV6b L1
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genes, in which the L1 ORFs are substituted with codons
preferentially used in the mammalian genome. We made
about 250 base substitutions in 250 codons rarely used in
mammalian cells to produce unmodified L1 proteins encoded
from the L1 ORFs with consensus codon usage using the
strategy previously reported (20). All the wt and codon-
modified PV L1 sequences were sequenced and found to
be error free; they were then cloned into the mammalian
expression vector pCDNA3 containing SV40 ori (Invitrogen,
Australia), giving four expression plasmids pCDNA3BPV1
L1, pCDNA3BPV1 HB L1, pCDNA3HPV6b L1 and
pCDNA3HPV6b HB L1.
Construction of hm gfp gene and serine GFP variants. As
described previously by Zhao et al. (35), a leader sequence
of six consecutive identical codons from one of the six serine
codons (AGC, AGU, UCA, UCC, UCG and UCU) was
introduced into an hm gfp gene (Invitrogen, Australia)
downstream from the AUG to produce six serine GFP variants.
All the serine GFP variant and hm gfp cDNAs were produced
from hm gfp by PCR using two flanking primers as described
previously (35) and ligated into the EcoRI and KpnI sites of
the pCDNA3 vector to construct seven GFP plasmids: hm
gfp, AGC GFP, AGU GFP, UCA GFP, UCC GFP, UCG
GFP and UCU GFP. All constructs were sequenced to ensure
that no PCR-induced mutations are introduced. The correct
orientations of all the plasmids used were confirmed by
enzyme restriction analysis before being used for transfection.
Cell culture and DNA transfection
CHO cells, grown in Ham’s F12 medium supplemented with
10% fetal bovine serum (FBS) (CSL, Australia), were brought
up to 70% confluence in monolayer and then transfected with
plasmid DNA using lipofectamine, following the instructions
provided by the manufacturer (Invitrogen, Australia). After
transfection, cells continued to grow in Ham’s F12 medium
supplemented with 10% FBS. Cos1 cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented
with 10% FBS. Cells were transfected with plasmid DNA
using Effectene reagent, following the instructions provided
by the manufacturer (Qiagen, Australia). After transfection,
cells continued to grow in DMEM medium supplemented with
10% FBS.
Establishment of BPV1 L1 expression cell lines
CHO or Cos1 cells were transfected with pCDNA3 BPV1 L1.
G418 (Invitrogen, Australia) supplemented medium was used
to select cells to establish two cell lines, CHO L1 and
Cos1 L1. Expression of BPV1 L1 was confirmed by PCR
after two or three passages; the cell lines were transfected
with pSV tRNASer(CGA) or control expression constructs.
Cells were collected 40 h after transfection and pelleted by
centrifugation for Hirt and total genomic DNA preparation
according to the methods described by Zhao et al. (34) and
Thomas et al. (36). The DNA samples were digested
overnight with DpnI/BamHI/EcoRI to remove any residual
input DNA. Digested DNA was electrophoresed on 1% agar-
ose and blotted on a nylon membrane. The membrane was
hybridized with 32P-labeled mixed probes of BPV L1 and
tRNASer(CGA) genes.
Protein sample preparation and western blotting
Both DNA-transfected CHO and Cos1 cells were collected for
protein preparation 42 h post-transfection. Cell pellets were
resuspended in phosphate-buffered 0.15 M sodium (PBS), pH
7.4, containing 2 mM phenylmethylsulpfnyl fluoride (PMSF)
and sonicated for 40 s. An aliquot of 30 mg of total protein
samples was resuspended in 40 ml of 1· Laemmli buffer (37),
boiled for 8 min and loaded onto a 10% (w/v) polyacrylamide
gel (SDS–PAGE) electrophoresis. After electrophoresis,
the gel was electrotransferred onto a PVDF membrane
(Bio-Rad). The blot was washed with PBS for 10 min, then
blocked in PBS containing 5% skim milk for 1 h at room
temperature and labeled with monoclonal antibody against
BPV1 L1 protein (26) overnight at 4C. The blot was incu-
bated with secondary antibody goat anti-mouse immuno-
globulin G (IgG) (Silenus, Australia), conjugated with
horseradish peroxidase (HRP) at room temperature for 4 h
and developed using an enhanced chemiluminescence
(ECL) kit (Amersham, Australia). The L1-probed blots
were stripped and relabeled with monoclonal antibody against
b-tubulin (Sigma, Australia) to confirm equal loading of
proteins samples.
Total RNA sample preparation and northern blot analysis
Total RNA was extracted from cells transfected with various
plasmids, using the Machery-Nagel RNAII Kit (Integrated
Sciences, Australia). An aliquot of 15 mg total RNA sample
digested with DNase I was electrophoresed in 1.2% denatured
agarose gels and blotted onto a Nylon N+ membrane
(Amersham, Australia), then hybridized either with a 32P-
labeled L1 gene or actin gene probe.
Immunofluorescence labeling
Cells were grown on 8-well chamber slides, transfected with
the different plasmids, fixed and permeabilized with 85%
ethanol for 42 h post-transfection. The fixed cells were then
blocked with 5% skim milk–PBS and probed with monoclonal
antibody against BPV1 L1 protein, followed by fluorescein-
isothiocyanate-conjugated (FITC) anti-mouse IgG (Sigma,
Australia). Nuclei were countstained by DAPI. Cells were
examined by immunofluorescent microscopy.
tRNA preparation and northern blot hybridization
Total tRNAs were extracted and purified using a Qiagen kit as
instructed by the supplier from CHO L1 or Cos1 L1 cell lines
with or without transfection of the tRNASer(CGA) gene. An
aliquot of 2 mg tRNA was fractioned by 10% denaturing PAGE
containing 8 M Urea and 0.1 M sodium acetate (pH 5.2).
Electrophoresis was carried out in 0.1 M sodium acetate
(pH 5.2) at 80 V for 5 h. After electrophoresis, the tRNA
gel was electroblotted onto Nytran Plus membrane in 40 mM
Tris–acetate (pH 4.2) and 2 mM EDTA at 20 V for 90 min at
4C. The membrane was crosslinked by 254 nm irradiation.
The blot was prehybridized with hybridization buffer contain-
ing 6· SSC, 10· DEN, 0.2% SDS and 1 mM EDTA at 37C
for at least 4 h. The blot was then hybridized with DNA
oligonucleotide probes complementary to the tRNASer(CGA)
and three other tRNAs: tRNALys(AAA), tRNALys(AAG) and
tRNAMet(initiator) in 4· SET buffer (1· SET = 0.15 M NaCl,
0.03 M Tris–HCl, 2 mM Na2EDTA, pH 8.0) at 37
C
4450 Nucleic Acids Research, 2004, Vol. 32, No. 15
overnight. The DNA oligonucleotide probes complementary
to the tRNASer(CGA) is 50-CCTGAGCTTTAGGTTACC-30;
to tRNALys(AAA) is 50-TCACTATGGAGATTTTA-30, to
tRNALys(AAG) is 50-CGCCCAACGTGGGGCTC-30 and to
the tRNAMet(initiator) is 50-TAGCAGAGGATGGTTTC-30.
The DNA oligomers were labeled with T4 polynucleotide
kinase and [g-32P]ATP (3000 Ci/mmol, Amersham) at the
first 50 end. Specific activities of 108 to 109 c.p.m./mg were
generally reached. Approximately 107 c.p.m. of oligomers was
used per blot in hybridization reactions. Blots were washed
with 1· SET buffer at 37C and autoradiographed.
Aminoacyl-methionine-tRNA determination
The tRNA samples were used for direct analysis of aminoacyl-
methionine-tRNA (aminoacyl-Met-tRNA). An aliquot of 2 mg
tRNA sample was treated with Tris base to strip aminoacyl-
tRNAs (0.5 M of Tris, pH 9.0, 37C for 30 min), and the
2 mg tRNA sample was left untreated as control. Both Tris-
treated and untreated tRNAs were fractioned by a denaturing
PAGE and blotted onto Nytran Plus membrane described as
above. The blot was then probed with DNA probes complemen-
tary to either tRNASer (CGA) or tRNAMet (initiator) as above.
Synthesis of cellular proteins
Synthesis of cellular proteins in CHO L1 or Cos1 L1 cell lines
with or without transient transfection of the tRNASer(CGA)
gene or pSVneo vector was studied by labeling with
[35S]methionine. Cells at 32 h after transfection were incu-
bated in 2 ml of medium supplemented with 10 mCi of
L-[35S]Met (370 kBq) for 4 h. This extended labeling time
is required to incorporate sufficient radioactivity into the
newly synthesized proteins, a consequence of the relatively
slow growth rates of these G418-treated cells. An aliquot of
10 mg protein sample was separated by 10% SDS–PAGE.
Gels were stained with Coomassie blue or dried and
autoradiographed.
RESULTS
Co-transfection of tRNASer(CGA) assists protein
expression of PV wt L1 genes
Expression of the BPV1 L1 gene in cell-free translation sys-
tems is enhanced by the addition of exogenous tRNAs (20). To
study whether provision of a single tRNA species similarly
affected L1 expression, we examined BPV1 L1 transcription
and translation in CHO and Cos1 cells transfected with BPV1
L1 gene constructs, either unmodified or codon modified to
match eukaryotic consensus codon usage, and co-transfected
with a tRNASer(CGA) expression construct. Northern blot
hybridization revealed that both cell lines effectively
transcribed BPV1 L1 whether or not codon modified
(Figure 1A), confirming previous results obtained in our
laboratory (20). Co-transfection of the tRNASer(CGA) expres-
sion construct did not affect the transcription of the BPV1 L1
gene in the two cell lines (Figure 1A). We then examined
whether the L1 protein was expressed (Figure 1B). Neither
cell line produced detectable L1 protein when transfected with
the BPV1 wt L1 gene (Figure 1B), though, as previously
shown (20), the codon-modified L1 gene was expressed.
The L1 protein was expressed from the BPV1 wt L1 gene
in cells co-transfected with the tRNASer (CGA) expression
construct (Figure 1B). Immunofluorescent labeling confirmed
that the L1 protein was expressed in both CHO and Cos1
cells following co-transfection of the BPV1 wt L1 and the
tRNASer(CGA) expression constructs (Figure 1C). We also
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Figure 1. Translation of BPV1 L1 mRNA is enhanced by provision of tRNASer(CGA). CHO or Cos1 cells were transiently transfected with (i) pCDNA3, (ii)
pCDNA3 + pSVtRNASer(CGA), (iii) pCDNA3BPV1 L1, (iv) pCDNA3BPV1 L1 + pSVtRNASer(CGA) and (v) pCDNA3BPV1 HBL1 (codon modified). (A).
Northern blot hybridization of L1 mRNA transcription. RNA samples were prepared at 42 h post-transfection. Of each sample of DNase-I-digested total RNA, 10 mg
was electrophoresed on a 1.2% denatured agarose gel and blotted onto a nylon membrane. The northern blots were hybridized with 32P-labeled wt and HB L1 probe
mixture. As controls, the northern blots were hybridized with 32P-labeled actin gene probe. (B) Immunoblotting analysis of the L1 protein. Monoclonal antibody
against BPV L1 protein was used to probe the blots. Upper panels show the results of L1 immunoblotting assay; lower panels show the results of b-tubulin
immunoblotting assay indicating equal loading of the protein samples. (C) L1 expression in CHO and Cos1 cells co-transfected with pCDNA3BPV1 L1 and
pSVtRNASer(CGA) was demonstrated by indirect immunofluorescence microscopy. Upper panels show the L1 labeling; lower panels show the nuclear staining
by DAPI.
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tested whether the tRNASer(CGA) gene could affect
expression of the L1 gene from HPV 6b in the two cell
lines, and similar results were obtained (data not shown).
Thus, the tRNASer(CGA) gene product appeared to assist
expression of L1 protein encoded by PV wt L1 genes in repli-
cating mammalian cells.
To confirm that enhanced translation of L1 mRNA was
specifically related to the expression of the tRNASer(CGA)
gene, we examined the effects of translation of cells with
the pSVNeo basal vector or with exogenous supplementation
of yeast tRNAs. L1 was effectively transcribed in BPV1 L1
transfected cells, whether or not the cells were co-transfected
with the pSVNeo basal plasmid or exposed to exogenous yeast
tRNAs (Figure 2A). However, the L1 protein was only
detected in cell lines co-transfected with the BPV1 L1 and
tRNASer(CGA) expression constructs (Figure 2B). Results
further indicate that expression of the tRNASer(CGA) gene
can thus assist translation of BPV1 L1 protein in non-
differentiated mammalian cells.
tRNASer(CGA) induces L1 protein expression
in cell lines stably transfected with L1 gene
To examine whether enhanced translation of the BPV1 L1
gene, when co-transfected with the tRNASer(CGA) expression
construct, is due to a consequence of their co-transfection or
expression of the tRNASer(CGA) gene, we established cell
lines, CHO L1 and Cos1 L1, stably transfected with a
BPV1 L1 expression construct (Figure 3A). Multiple replica-
tion forms revealed by Southern blot hybridization using total
genomic DNA samples confirmed the presence of integrated
BPV1 L1 genes (data not shown). However, the episomal
format of the BPV1 L1 gene was also observed in Hirt
DNA samples, presumably because of passage number of
the cell lines (Figure 3B). The tRNASer(CGA) gene was
only detected in the two L1 cell lines following
transfection with the tRNASer(CGA) expression construct
(Figure 3B).
The two L1 cell lines transcribed the BPV1 L1 gene equally,
whether they were transfected with the tRNASer(CGA) gene or
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Figure 2. Enhancement of translation of BPV1 wt L1 mRNA by
tRNASer(CGA) is specific. CHO or Cos1 cells were transiently transfected
with (i) pCDNA3 (mock 1), (ii) pCDNA3BPV1 L1 (mock 2), (iii)
pCDNA3BPV1 L1 plus exogenous supplement of yeast tRNAs in culture
medium (commercial bake yeast tRNAs from Sigma, Australia, were added
into CHO or Cos1 cell cultures at 1mg/ml following transfection of BPV1 wt L1
expression construct),(iv) pCDNA3BPV1 L1 plus pSVneo basal vector, and (v)
pCDNA3BPV1 L1 plus pSVtRNASer(CGA). (A). Northern blot hybridization
of L1 mRNA transcription. RNA samples were prepared at 42 h post-
transfection. Of each sample of DNase-I-digested total RNA, 10 mg was
electrophoresed on a 1.2% denatured agarose gel and blotted onto a nylon
membrane. Northern blots were hybridized with 32P-labeled BPV1 wt L1
probe (upper panel). As controls, the northern blots were also hybridized
with 32P-labeled actin gene probe (lower panel). (B) Western blotting
analysis of L1 protein. Monoclonal antibody against BPV L1 protein was
used to probe on the blot. Upper panels show the results of L1
immunoblotting assay; lower panels show the results of b-tubulin
immunoblotting assay indicating equal loading of the protein samples.
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Figure 3. Replication of BPV1 L1 and tRNASer(CGA) genes in CHO L1 and Cos1 L1 cells. (A) PCR analysis of DNA prepared from CHO L1 or Cos1 L1 cells,
confirming that the cell lines retained a BPV1 L1 expression construct. (B) Southern blot analysis of Hirt DNA for BPV1 L1 and tRNASer(CGA) gene replication
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Southern blot was hybridized with a mixture of 32P-labeled BPV1 L1 and tRNASer(CGA) gene probes.
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a basal plasmid and also when exposed in culture to exogenous
yeast tRNAs (Figure 4A). However, the L1 protein was pro-
duced only in cell lines transfected with the tRNASer(CGA)
expression construct, but not with control plasmids, and/or
supplemented with exogenous yeast tRNAs. Again, immuno-
fluorescent labeling confirmed that L1 protein was produced in
the two L1 cell lines after transfection of the tRNASer(CGA)
gene (Figure 4C). The results confirm further that the L1
protein was produced due to the presence of the tRNASer
(CGA) gene product.
Action of tRNASer(CGA) on expression of
BPV1 wt L1 protein is specific
To examine whether the transfection itself might induce
expression of the BPV1 L1 protein, we transfected CHO L1
cell lines with not only the tRNASer(CGA) expression con-
struct, but also several vectors including pIBT100, pUC19,
pcDNA3 and pSVneo. No L1 protein expression was detected
following the transfection of the control vectors in CHO L1
cells (Figure 5), suggesting further that expression of the
BPV1 L1 protein was due to the tRNASer(CGA) gene product.
tRNASer(CGA) results in enhanced expression
of other tRNA species
It was unexpected that the expression of a single tRNA gene
would induce translation of wt PV L1 mRNAs as the block to
translation might be expected to be a consequence of shortages
of many tRNA species critical to optimal translation of this
gene. Thus, to determine why this might occur, we examined
whether the transduced tRNASer(CGA) gene affected expres-
sion of tRNAs other than tRNASer(CGA) in the two L1 cell
lines. We first used polyacrylamide gel electrophoresis to frac-
tionate total tRNAs, prepared from CHO L1 and Cos1 L1 cell
lines, either untransfected or following transfection of
the tRNASer(CGA) expression construct. As shown in
Figure 6A, total tRNA populations prepared from the two
L1 cell lines differed according to whether they had been
transfected with the tRNASer(CGA) gene (Figure 6A). Several
extra tRNA bands in relative low molecular weights were
observed in the L1 cell lines after transfection of the
tRNASer(CGA) gene (Figure 6A), suggesting that expression
of the tRNASer(CGA) gene may result in enhanced production
of new tRNA species.
We arbitrarily chose four oligonucleotide probes that were
complementary to specific regions of the four tRNA
species, tRNASer(CGA), tRNALys(AAA), tRNALys(AAG)
and tRNAMet(AUG) for northern blot analysis. The four
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probes mixed to detect the tRNA blot revealed that expres-
sion of the tRNASer(CGA) gene slightly increased the signals
of the four tRNAs in the two L1 cell lines based on densito-
metric analysis (data not shown). To further examine whether
the tRNASer(CGA) gene affected aminoacylation of the
tRNA species in the two L1 cell lines, we detected
the different forms (uncharged and aminoacyl-tRNAs) of
the tRNASer(CGA) and initiator tRNAMet(AUG) by northern
blot hybridization. The tRNASer(CGA) gene increased
slightly the levels of aminoacylation of the tRNASer(CGA)
in both L1 cell lines (data not shown). In contrast, two forms
of uncharged and aminoacyl-tRNAMet(AUG) were well-
separated in Cos1 L1 cells (Figure 6B), although not in
CHO L1 cells. A high percentage of the tRNAMet(AUG)
was aminoacylated (Figure 6B), and tRNASer(CGA) gene
significantly increased the levels of aminoacylation of the
tRNAMet(AUG) in Cos1 L1 cell line (Figure 6B), suggesting
that expression of the tRNASer(CGA) gene may affect
translation initiation.
tRNASer(CGA) induces phosphorylation of
translation initiation factors
We then examined the phosphorylation status of two transla-
tion initiation factors, elF4E and elF2a, in the L1 cell lines
with or without transfection of the tRNASer(CGA) gene to
investigate whether the tRNASer(CGA) gene product affects
phosphorylation of the translation initiation factors (Figure 7).
By performing western blotting analysis with antibodies that
specifically recognize the phosphorylation forms of elF4E and
elF2a, no phosphorylation of both elF4E and elF2a was
observed in CHO L1 and Cos1 L1 cells (Figure 7), in contrast,
phosphorylated elF4E and elF2a were detected in CHO L1
and Cos1 L1 cells transfected with the tRNASer(CGA) gene
(Figure 7). At the same time, the phosphorylation levels of
both elF4E and elF2a are much higher in CHO L1 cells than in
Cos1 L1 cells. Consistent with the L1 protein detected only in
both CHO L1 and Cos1 L1 cells transfected with the tRNASer
(CGA) gene (Figure 7), the results suggest that the phosphor-
ylation of the two translation initiation factors elF4E and
elF2a induced by the tRNASer(CGA) gene product may be
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Figure 7. Effects of the tRNASer(CGA) gene product on phosphorylation of two
translation initiation factors, elF4e and elF2a, in CHO L1 and Cos1 L1 cell
lines. Protein samples of 40 mg prepared from the two L1 cell lines with or
without transfection of the tRNASer(CGA) gene were resolved by SDS–PAGE,
transferred to the PVDF membrane, and analyzed by western blotting with
antibodies against L1 (top panel), eIF4E-P phosphorylated at serine 209 [eIF4E-
P (Ser 209), middle panel] and eIF2a-P phosphorylated at serine 51[eIF2a-P
(Ser 51), bottom panel].
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involved in enhancing the translation of the L1 protein in the
two cell lines examined.
tRNASer(CGA) increases yields of the total
cellular proteins
As both the alteration of tRNA populations and the increased
aminoacylation of initiator tRNAMet(ATG), together with the
phosphorylation of both elF4e and elF2a, might impact on the
synthesis of cellular proteins, we examined whether expres-
sion of the tRNASer(CGA) gene affected the production
of cellular proteins in the two L1 cell lines. Cells (1 ·
106/well) either untransfected or following transfection with
the basal pSVneo vector and the tRNASer(CGA) gene were
cultured for 48 h and collected for total protein analysis.
Untransfected CHO L1 cells and the CHO L1 cells following
transfection of the basal pSVneo vector produced significantly
less proteins (0.547 – 0.011 mg and 0.566 – 0.014 mg,
respectively) than CHO L1 cells following transfection of
the tRNASer(CGA) gene (0.606 – 0.015 mg) (Figure 8A).
Cos1 L1 cells following transfection of the tRNASer(CGA)
gene produced 0.690 – 0.009 mg protein, slightly more
than untransfected Cos1 L1 cells (0.665 – 0.008 mg) and
the pSVneo-transfected Cos1 L1 cells (0.653 – 0.012 mg)
(Figure 8A). SDS–PAGE was used to fractionate equal
amounts of the cellular proteins from the two L1 cell lines
either untransfected or following transfection with basal
pSVneo vector and the tRNASer(CGA) gene, which was stained
with Commasie blue (Figure 8B). The SDS–PAGE profiles of
the total cellular proteins in the two L1 cell lines with or
without transfection of the tRNASer(CGA) gene are different
(Figure 8B). But transfection of the basal pSVneo vector
appeared not to affect the SDS–PAGE profiles of the total
cellular proteins in the two L1 cell lines (Figure 8B). The
levels of some cellular proteins were significantly enhanced
by the tRNASer(CGA) gene (Figure 8B). At the same time, a
few proteins seemed to be reduced in their amounts in the L1
cells after transfection with the tRNASer(CGA) gene. These
observations were confirmed by [35S]methionine labeling
experiments (Figure 8B), suggesting that the tRNASer(CGA)
gene product had negative effects on the synthesis of some
cellular proteins, although it increased the yields of the total
cellular proteins in the two L1 cell lines.
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Figure 8. Effects of the tRNASer(CGA) gene product on cellular proteins in CHO L1 and Cos1 L1 cell lines. (A) Yields of total cellular proteins. CHO L1 and Cos1 L1
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tRNASer
ðCGAÞ
reduces expression of the
L1 proteins encoded by codon-modified PV L1 genes
To explain why the tRNASer(CGA) gene overexpression has
variable effects on expression of different cellular proteins, we
hypothesize that the matching between tRNAs and codon
usage of the genes regulates expression of the cellular proteins
in the cells. To test our hypothesis, we examined whether the
tRNASer(CGA) gene could affect expression of L1 protein
encoded by a codon-modified BPV1 L1 gene (BPV1 HB
L1), which has been demonstrated to translate L1 protein
in large amounts in replicating mammalian cells in previous
studies (20,30) and in the current one (Figure 1B). Both CHO
and Cos1 cells transfected solely with BPV1 HB L1 gene or
co-transfected with BPV1 HB L1 and tRNASer(CGA) genes,
were incubated for 42 h and collected for L1 mRNA and
protein expression analysis (Figure 9). Northern blot hybridi-
zation confirmed that the BPV1 HB L1 gene is effectively
transcribed (Figure 9A). No significant differences in the
levels of L1 mRNA between transfection solely with BPV1
HB L1 gene and co-transfection with BPV1 HB L1 and
tRNASer genes were observed (Figure 9A), which was con-
firmed by quantitative RT–PCR analysis using the L1 mRNAs
(data not shown). However, western blot analysis shows that
the tRNASer(CGA) gene resulted in a reduction in the levels of
the L1 protein expressed from the BPV1 HB L1 gene by >50%
(Figure 9B) in the two cell lines, whereas b-tubulin
expression remained unaffected (Figure 9B). To confirm
these observations, we examined whether expression of
another codon-modified PV L1 gene, HPV6b HB L1, was
also affected by expression of the tRNASer(CGA) gene
(Figure 9B). The results (Figure 9) are in agreement with
those obtained in the experiments using BPV1 HB L1 gene,
supporting the idea that tRNAs may complement the
codon composition of genes to regulate gene translation in
mammalian cells.
tRNASer(CGA) differentially regulates expression of
serine GFP variants
Based on the above results (Figure 9), we hypothesize further
that the tRNASer(CGA) gene may favor the expression of the
target genes in which UCG or other codons from the six serine
codons are used more frequently. To test this hypothesis, we
studied transcription and translation of the hm gfp gene and the
six serine GFP variants in both CHO and Cos1 cells either
transfected solely with hm gfp and six serine GFP variants or
co-transfected with the GFP expression constructs and the
tRNASer(CGA) gene. The serine GFP variants express
the same protein sequences, but the six additional serines at
the N-terminal of their GFP molecules following the AUG
codon were encoded by one of the six serine codons (AGC,
AGU, UCA, UCC, UCG and UCU), respectively. Northern
blot hybridization revealed that the hm gfp gene and the six
serine GFP variants were transcribed effectively in the two cell
lines and co-transfection of the tRNASer(CGA) gene did not
affect significantly the levels of their transcripts (data not
shown). Western blot analysis first shows that all six serine
GFP variants exhibited levels of immunoreactive GFPs sig-
nificantly higher than hm gfp gene (Figure 10A), confirming
our previous study that addition of serine codons to hm gfp
gene downstream from the AUG increased significantly
steady-state levels of GFP (35). Then, western blot analysis
shows that co-transfection of the tRNASer(CGA) gene barely
affected the levels of immunoreactive GFPs produced by hm
gfp gene and two serine (AGC and UCU) GFP variants
(Figure 10B). However, tRNASer(CGA) increased significan-
tly the levels of immunoreactive GFPs produced by AGU and
UCG GFP variants (Figure 10B), in contrast to the significant
reduction of the level of immunoreactive GFPs produced by
the UCA GFP variant followed the co-transfection of the
tRNASer(CGA) gene (Figure 10B). Moreover, tRNASer(CGA)
slightly increased the level of immunoreactive GFP produced
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Figure 9. Effects of the tRNASer(CGA) expression construct on expression of L1 proteins encoded by codon-modified PV L1 genes (BPV1 HB L1 and HPV6b HB
L1) in CHO and Cos1 cells. (A) L1 mRNA levels. CHO or Cos1 cells were transiently transfected with PV HB L1 gene construct only, or with PV HB L1 gene
construct and the tRNASer(CGA) gene. (B) L1 protein expression. Four dilutions of protein samples from cells either transfected with PV HB L1 gene construct only,
or co-transfected with PV HBL1 gene construct and the tRNASer(CGA) gene were loaded onto SDS-PAGE gel for protein fractionation and blotted on PVDF
membranes for immunoblotting assay. Monoclonal antibody against BPV L1 protein was used to probe the blots. Upper panels show the results of L1 immunoblotting
assay; lower panels show the results of b-tubulin immunoblotting assay indicating equal loading of the protein samples between two treatments.
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Figure 10. Variable effects of the tRNASer(CGA) expression construct on expression of GFPs encoded by hm gfp and six serine GFP variants in CHO cells. (A)
Protein expression of hm gfp and six serine GFP variants in CHO cells transiently transfected solely with the seven GFP plasmid DNAs 42 h post-transfection. Protein
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by UCC GFP variants (Figure 10B). In the parallel experi-
ments, we used flow cytometry analysis (FAC) to examine
fluorescence intensity in both CHO and Cos1 cells either trans-
fected solely with hm gfp and six serine GFP variants, or co-
transfected with the GFP expression constructs and the
tRNASer(CGA) gene. Results obtained from the FAC analysis
(data not shown) confirmed the western blotting analysis
for immunoreactive GFPs produced by the hm gfp gene and
six serine GFP variants in the two cell lines, proving our
hypothesis.
DISCUSSION
In the present study, supplementation of exogenous tRNAs did
not enhance the translation of PV wt L1 genes in two cell lines.
The results cannot confirm our and other previous observations
that supplementation of exogenous tRNAs enhanced the trans-
lation of PV L1 and E7 genes in in vitro translation systems
(20,30), but they are consistent with the studies carried out by
the other researchers that exogenous tRNAs have no effect on
protein synthesis in permeabilized cells (32,38). The major
reason is different translation machinery used in the in vitro
translation systems and cell culture systems. Using CHO cell
system, previous work has provided strong evidence that the
translation apparatus is highly organized in cultured cells (32).
Exogenous tRNAs cannot enter the translation machinery in
cultured cells despite the fact that exogenous tRNA can rapidly
distribute throughout the cells and can be aminoacylated by
minor portion of the cellular aminoacyl-tRNA synthetases
(aaRS) in permeabilized cells (38). Moreover, exogenous
aminoacyl-tRNA in permeable cells is not sequestered and
protected against RNase treatment, in contrast to endogenous
tRNA molecules (39), because during translation endogenous
tRNAs are never in a state in which they can mix with and be
competed against by exogenous tRNA molecules (38). All of
the above observations may explain why exogenous tRNAs
did not play a role in enhancing the translation of PV L1
mRNA in both CHO and Cos1 cells examined in the present
study if they were efficiently taken up by the two cell lines. It
is also possible that exogenous tRNAs were not taken up by
the cells so no functional roles could be identified.
Previous studies have indicated that changes of physiolo-
gical factors resulted in alteration in the populations of specific
or total tRNAs in the mammalian tissues or cells (40–44). For
example, ovariectomy resulted in alterations in the population
of uterine serine tRNA (40). Due to carcinogenesis, cellular
tRNA distribution was shifted in the tRNA population with an
increased level of initiator tRNAMet in the malignant tissues
(44). Selenium, an essential trace element that functions in
proteins (selenocysteine, Sec) critical for a variety of cellular
processes, influences the level of the Sec tRNA[ser]sec popula-
tion and the distribution of the Sec tRNA[ser]sec isoacceptors in
both mammalian cells grown in culture (45) and mammalian
tissues (46) and the turnover of Sec tRNA[ser]sec in CHO cells
(43). The present data indicate further that the expression of
the tRNASer(CGA) gene increased not only the relative levels
of the tRNASer(CGA) and the initiator tRNAMet but also prob-
ably resulted in new tRNA species produced in the two cell
lines. Consequently, expression of the tRNASer(CGA) gene
altered the gel profiles of the total tRNAs in the two cell
lines. Our results are in agreement with previous studies
(47–52) in that genes for expressing tRNA species introduced
into cells change tRNA contents in the targeted cells. Thus, all
the observations suggest that mammalian cells may have a
sensitive mechanism to sense and respond to both changes
in physiological factors and introduction of foreign tRNA
genes, by altering their tRNA populations.
Here, expression of the tRNASer(CGA) gene was identified
to enhance the expression of L1 proteins encoded by the PV wt
L1 genes and of GFPs encoded by two (UCG and AGU) serine
variants in two cell lines examined. Previously, there have
been examples in which synthesis of a specialized protein
is associated with expression of a single tRNA gene due to
modification of the tRNA population in different expression
systems (9,10). Expression of the tRNASer(CGA) gene was
then found to increases the synthesis of some cellular proteins
in the present study. As a result, expression of 5–10% of total
cellular proteins was increased in the L1 cells following trans-
fection of the tRNASer(CGA) gene when compared to the
control L1 cells. Our results support previous studies that
tRNAs, even a single tRNA, affect protein expression encoded
by heterologous genes in different expression systems
(9,10,20,30,40,41). For example, tRNAs from oviducts of
estrogen-stimulated chicks or from oviducts of laying hens
produced an enhanced stimulation of ovalbumin synthesis
in vitro (40). The use of tRNA (AGA/AGG) increased
human interferon HUIFN-a2 and HCV core protein expression
(9,10), but barely affected the human IFN-a8 expression in
an E.coli expression system (9,10). However, expression of
the tRNASer(CGA) gene reduced expression of L1 proteins
encoded by the PV HB L1 genes and of GFP encoded by
UCA serine variant and of some cellular proteins. The result
was consistent with a few other studies. A tRNASer(UCN)
gene flanked with the deafness-associated mitochondrial
DNA (mtDNA) T7445C mutation at the 30 end causes an
average reduction of 70% in the levels of the tested proteins
and a decrease of 45% in protein synthesis rate in the cell
lines analyzed (53). Recently, Akama and Beier (54) reported
that co-transfection of Arabidopsis hypocotyls with amber
suppressor tRNASer(CGA) gene and the GUS reporter gene
resulted in 10% of the GUS activity found in the same tissue
transformed solely with the GUS gene. Therefore, we can
speculate that contents and modifications of the endogenous
tRNAs have effects on the expression of a large number of
both foreign and host genes through tRNA function in transla-
tion in mammalian cells. Our findings are consistent with the
conclusion that the host cell tRNAs can affect the synthesis of
gene products quantitatively and qualitatively in translating
heterologous genes (55,56).
The most interesting finding in the present study is that the
tRNASer(CGA) gene had variable effects on expression of the
PV wt and HB L1 genes and of hm gfp gene and serine GFP
variants at protein translational levels in the two cell lines
examined. Previous studies have reported that the expression
of the PV capsid genes (L1 and L2) is controlled by several
means: the late viral promoters depend on the differentiation
status of the cells, polyadenylation signals terminate transcrip-
tion before reaching the late regions (57–60) and mRNAs
encoding the capsid proteins contain inhibitory elements
that prevent nuclear export or destabilize the message
(19,61–66). However, none of these studies produced the
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PV L1 and L2 proteins expressed from the wt L1 and L2 genes
in replicating mammalian cells. In contrast, previous findings
in our laboratory have indicated that a strong bias in codon
usage is apparent between the papillomavirus and its host,
which blocks BPV1 capsid genes from expressing their pro-
teins in non-differentiated mammalian cells (20,33). On the
basis of the hypothesis that the match between codon usage
and tRNA contents regulates the gene expression at the protein
levels (20), the limitation of PV capsid protein expression has
been overcome by modifying the codon usage of these genes
toward mammalian ‘consensus’ without changing the protein
sequence, demonstrating that codon usage is one of the
determinants of the rate of HPV gene expression in non-
differentiated mammalian cells (20,22–24,67). In the present
study, we take a different approach to test the hypothesis that
the match between codon usage and tRNAs regulate PV L1
genes to express their proteins. We expressed a tRNASer(CGA)
gene in the two non-differentiated cell lines. Expression of the
tRNASer(CGA) gene resulted in alterations in tRNA patterns
in the two cell lines examined, which enhanced translation of
two PV wt L1 mRNAs that contain large numbers of the
codons rarely used by mammalian genes (20,33). Meanwhile,
the enhanced expression of the serine UCG GFP variant
was probably corresponding to the expression of the
tRNASer(CGA) gene according to a previous statement that
correct translation of the UCG codon depends on the
tRNASer(CGA) molecule (68). Although it has been reported
that tRNA1
Ser(G34) with the anticodon GGA can recognize not
only UCC and UCU codons but also UCA and UCG codons
(69), but the enhanced expression of the serine AGU GFP
variant by the expression of the tRNASer(CGA) gene is pre-
sently not understood. Moreover, we observed that expression
of the tRNASer(CGA) gene resulted in a dramatic reduction
in the translation of PV HB L1 and UCA serine GFP variant
mRNAs in the two cell lines. Thus, the phenomena observed in
the present study may be well explained by two previous
statements by Del Tito et al. (55) and Hatfield et al. (70).
These statements have described how the tRNAs in cells
are related to the gene expression at translation levels: (i) if
the level of certain tRNAs was low, then one would predict
translational difficulties in decoding mRNA species contain-
ing large numbers of the rare codons (55) and (ii) the cellular
content of tRNA species often correlates positively with the
codon bias of mRNAs for the major homologous protein pro-
ducts (70). Taken together with these statements (55) and our
previous studies (20), current data strengthen support for the
hypothesis that codon usage matches tRNAs to regulate
expression of the target genes in both non-differentiated
and differentiated epithelium.
Recently, Walsh and Mohr (71) provided the first evidence
that phosphorylation of the translation initiation factor elF4E
by the elF4E kinase mnk-1 is crucial for viral protein synthesis
and replication of the herpes simplex virus-1 (HSV-1) in
quiescent cells. Consistent with their report, phosphorylation
of the two translation initiation factors elF4E and elF2a
induced by the tRNASer(CGA) gene appears to be required
for the translation of the PV wt L1 mRNAs in the two cell lines
examined in the present study. In contrast to this expectation,
however, the phosphorylation of elF4E and elF2a may have
selective effects, even reducing the translation of the PV HB
L1 and serine UCA GFP mRNAs. Thus, the expression of the
tRNASer(CGA) gene was able to regulate the phosphorylation
levels of both elF4E and elF2a, suggesting that another pos-
sible mechanism is involved by which the PV L1 genes and
serine GFP variants may differentially regulate cap-dependent
and cap-independent translation initiation.
Based on our observations, we can conclude that alterations
in tRNAs and phosphorylation of elF4E and elF2a caused
by the expression of the tRNASer(CGA) gene are important
in modulating expression of the PV L1 genes with different
codon usage and serine GFP variants at protein translational
levels in the two cell lines. However, tRNAs must associate
with their cognate aaRSs that catalyze the attachment of a
particular amino acid to the 30 end of an appropriate tRNAs
containing the anticodon corresponding to that amino acid to
generate aminoacyl-tRNAs necessary for protein synthesis.
But, it is not clear whether the expression and activities of
any aaRSs is affected by the tRNASer(CGA) gene. Detailed
studies are therefore necessary to examine how expression
of the tRNASer(CGA) gene affects the other components of
the protein-synthesizing machinery, including the aaRSs and
the elongator factors in the two cell lines.
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